Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APLS

Apellis Pharmaceuticals Inc

May 06 • 04:00PM ET

41.12

+0.15 0.37 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: AMGN REGN SRPT MRNA BMRN EXEL VRTX PBYI UTHR KURA

| Held by: IJR XBI VTI VB VBK VXF SPSM IJT IWP IBB

Scroll to Statements

Index	-	P/E	332.96	EPS (ttm)	0.12	Insider Own	30.77%	Shs Outstand	126.62M	Perf Week	0.42%
Market Cap	5.26B	Forward P/E	-	EPS next Y	-0.13	Insider Trans	-0.33%	Shs Float	88.63M	Perf Month	1.03%
Enterprise Value	5.27B	PEG	-	EPS next Q	-0.34	Inst Own	85.94%	Short Float	16.07%	Perf Quarter	77.62%
Income	22.39M	P/S	5.24	EPS this Y	-657.91%	Inst Trans	-11.02%	Short Ratio	2.90	Perf Half Y	98.74%
Sales	1.00B	P/B	14.07	EPS next Y	88.67%	ROA	2.28%	Short Interest	14.24M	Perf YTD	63.69%
Book/sh	2.92	P/C	11.25	EPS next 5Y	82.23%	ROE	7.48%	52W High	41.00 0.29%	Perf Year	115.06%
Cash/sh	3.65	P/FCF	116.96	EPS past 3/5Y	- -	ROIC	3.01%	52W Low	16.10 155.40%	Perf 3Y	-55.87%
Dividend Est.	-	EV/EBITDA	92.50	Sales past 3/5Y	136.98% 31.98%	Gross Margin	89.69%	Volatility	0.16% 0.19%	Perf 5Y	-11.53%
Dividend TTM	-	EV/Sales	5.25	EPS Y/Y TTM	110.72%	Oper. Margin	5.52%	ATR (14)	0.45	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.70	Sales Y/Y TTM	28.46%	Profit Margin	2.23%	RSI (14)	87.25	Recom	2.90
Dividend Gr. 3/5Y	- -	Current Ratio	3.14	EPS Q/Q	-59.44%	SMA20	0.51%	Beta	-0.24	Target Price	40.82
Payout	0.00%	Debt/Eq	1.28	Sales Q/Q	-5.94%	SMA50	35.48%	Rel Volume	0.76	Prev Close	40.97
Employees	739	LT Debt/Eq	1.01	Earnings	Feb 24 BMO	SMA200	62.38%	Avg Volume	4.92M	Price	41.12
IPO	Nov 09, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-25.67% 0.26%	Trades		Volume	3,719,971	Change	0.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)